Position in LQDA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,036
New position
Shares Held
13
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#320
of 333 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Plante Moran Financial Advisors, LLC holds $47,094 across 18 Drug Manufacturers - Specialty & Generic names. LQDA ranks #7 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
250 | $17,965 | |
| 2 | VTRS |
Viatris Inc
|
677 | $10,750 | |
| 3 | EOLS |
Evolus, Inc.
|
1,220 | $8,466 | |
| 4 | ALKS |
Alkermes plc.
|
41 | $2,148 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
49 | $1,660 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
74 | $1,186 | |
| 7 | LQDA |
Liquidia Corp
This page
|
13 | $1,036 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
|
15 | $615 |
All Filings in LQDA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,036 | 13 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||